Carta Healthcare, which offers AI technology that helps abstract data faster, announced they acquired Realyze Intelligence, a portfolio company of UPMC Enterprises.
The companies aim to expand and strengthen their combined AI platforms.
Realyze Intelligence platform leverages AI to match patients to clinical trials to expedite research and lower costs, while providing patients with the newest...
Antidote Technologies, a digital patient engagement company, announced it is partnering with SEQSTER, a multidimensional healthcare data platform, to identify patients for clinical trials and improve trial timelines.
Antidote offers a clinical trial patient-recruitment platform that includes patient screening and support services.
The company will leverage SEQSTER's operating system to better...
Oncology-focused digital health company Flatiron Health, which Roche acquired in a $1.9 billion deal in 2018, is announcing a strategic collaboration with the Association of Cancer Care Centers (ACCC) to promote access to clinical trials in the community setting, improve clinical study efficiency and enhance the gathering of study-related data.
ACCC is an advocacy group comprising a nationwide...
The FDA announced the Apple Watch atrial fibrillation (AFib) tool is qualified for use in clinical trials through its Medical Device Development Tools (MDDT) program, thus enabling researchers to use it to detect arrhythmias or abnormal heart beat.
Apple's tool is the first digital health tool to be qualified under the MDDT program, a voluntary program aimed at evaluating devices for use in...
Editor's note: This article has been updated with a comment from the NIH.
Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), have developed an artificial intelligence tool that predicts whether a patient will respond to cancer-treatment drugs using individual tumor cells, according to a study published in Nature Cancer.
Traditional approaches to...
Pharmaceutical giant AstraZeneca announced the launch of Evinova, a health technology business focused on bringing digital health solutions already in use globally by the pharma company to clinical research organizations (CROs), trial sponsors and care teams, and patients.
The new company will use established digital technology solutions to streamline clinical trial design and delivery in order...
Clinical trial startup Inato scooped up $20 million in a Series A2 funding round led by Cathay Innovation.
The raise included returning investor Obvious Ventures and new participants La Maison and Top Harvest Capital. The company previously raised $14 million in Series A funding in 2020.
WHAT IT DOES
Inato offers a technology platform that connects pharma companies and potential clinical trial...
The Digital Medicine Society (DiMe) and a suite of digital health and pharma players partnered to launch a toolkit aimed at improving diversity, equity and inclusion in clinical trials.
The resources include a guide to each step of a digital clinical trial, shared definitions of terms like "diversity" and "equity," a list of different digital tools that could be used and the potential benefits...
Clinical trial tech company Science 37 announced Thursday it has acquired a life science platform from Vault Health, which offers COVID-19 testing and health-screening services for employers.
Science 37 said the deal accelerates its plans to add features like advanced scheduling, investigational product tracking and data sharing with electronic data capture systems and EHRs.
The company said...
Tech-enabled clinical trial platform Paradigm announced its launch alongside a $203 million Series A funding round co-led by ARCH Venture Partners and General Catalyst.
F-Prime Capital, LUX Capital, GV, Magnetic Ventures and Mubadala Capital also participated in the round. American Cancer Society's BrightEdge fund was a strategic investor.
The company also announced its acquisition of Deep Lens...
